What happens when you take tirzepatide with warfarin?
Tirzepatide is a weekly injection: Mounjaro for blood sugar control in type 2 diabetes, and Zepbound for weight loss and for obstructive sleep apnea in adults with obesity. Warfarin (Jantoven and generics) is a blood thinner with a narrow safety range, checked with the INR blood test. Tirzepatide does not act on clotting, but it slows the stomach, which can change how warfarin tablets are absorbed.
- Tirzepatide slows the stomach. The labels say tirzepatide delays gastric emptying, most after the first dose, and the effect fades over time.
- Pill absorption can change. A slower stomach can change how fast or how much of an oral medicine is absorbed.
- Warfarin has little room for error. Small changes in warfarin's level can push the INR too high (bleeding risk) or too low (clot risk).
- Eating less matters too. Tirzepatide often reduces appetite, and big changes in diet, including vitamin K intake, can also move the INR.
Why is this important?
Both tirzepatide labels tell prescribers to monitor people on oral medicines with a narrow therapeutic index, and they give warfarin as the example. An INR that drifts too high raises the risk of bleeding; one that drifts too low raises the risk of stroke or a clot, which matters most for people with a mechanical heart valve or a past clot.
The evidence so far is thin. No warfarin study is reported on either label. Two case reports describe INR changes after tirzepatide: in one, a woman with a mechanical heart valve had a marked drop in INR 10 days after starting it; in the other, a man had an INR of 8.7 after a dose increase, alongside other serious illness. Studies of two other GLP-1 medicines, semaglutide and dulaglutide, in healthy volunteers found no clinically relevant change in warfarin's effect. So the risk is real enough to monitor, but how often it happens is unknown.
What should you do?
Before starting tirzepatide: Tell your prescriber and the person who manages your warfarin. They may plan extra INR checks for the first weeks.
After each dose increase: The labels say the stomach-slowing effect is largest after the first dose and fades over time, and their birth control advice covers the 4 weeks after each dose increase as well. Ask whether an extra INR check is useful after an increase, and mention big changes in how much you eat, too.
Every day: Take warfarin exactly as prescribed and never change the dose on your own. Get medical help for unusual bleeding or bruising, black or bloody stools, blood in the urine, or signs of a stroke or clot.
Which specific products are affected?
On the tirzepatide side: Mounjaro and Zepbound, in pens and vials. On the warfarin side: Jantoven and generic warfarin tablets (Coumadin is the older brand name).
The same label advice covers other oral medicines that need steady levels, but this page is about warfarin. Other GLP-1 medicines have their own labels and studies.
The science behind it
The Mounjaro prescribing information (DailyMed, section 7.2) says Mounjaro delays gastric emptying and thereby has the potential to impact the absorption of oral medications, and tells prescribers to "monitor patients on oral medications dependent on threshold concentrations for efficacy and those with a narrow therapeutic index (e.g., warfarin)." The Zepbound label (DailyMed, section 7.2) says the same. In label studies, a first dose of tirzepatide reduced the peak level of acetaminophen, a test drug for stomach emptying, by 50% (Mounjaro) to 55% (Zepbound) without changing total exposure, and the effect was gone after several weeks of treatment.
Two case reports point to a possible effect on INR. Natale R, et al. (Eur J Case Rep Intern Med. 2025; PMID 41064709) describe a 66-year-old woman with a mechanical mitral valve whose INR fell markedly 10 days after starting tirzepatide despite a stable diet; reaching her target took about three weeks of warfarin increases. Shakour H, et al. (Cureus. 2025; PMID 40225446) describe a 64-year-old man on warfarin whose INR was 8.7 after a tirzepatide dose increase; he also had vasculitis and kidney injury, so the cause is unclear.
Studies with other GLP-1 medicines did not show a clinically relevant warfarin effect in healthy volunteers: Hausner H, et al. (Clin Pharmacokinet. 2017; PMID 28349387) for injected semaglutide, and de la Pena A, et al. (Clin Pharmacokinet. 2017; PMID 28357715) for dulaglutide.
What was not shown: no controlled study has tested tirzepatide with warfarin, and two case reports are a signal, not proof.
Frequently Asked Questions
Can I take Mounjaro or Zepbound with warfarin?
Yes, many people do, but the labels say to monitor. Ask the person who manages your warfarin whether you need extra INR checks.
Does tirzepatide thin the blood?
No. It does not act on clotting. The concern is that it may change how warfarin is absorbed, and that eating much less can change your vitamin K intake.
When is the risk highest?
The labels say the stomach-slowing effect is largest after the first dose and fades over time; their birth control advice also covers the weeks after each dose increase. Starting tirzepatide and each dose increase are the times to ask about extra INR checks.
Should I change my warfarin dose when I start tirzepatide?
Never change it on your own. Your clinician decides based on your INR results.
What signs should I watch for?
Unusual bruising or bleeding, black or bloody stools, or blood in the urine can mean the INR is too high. Sudden weakness, trouble speaking, or a swollen painful leg can mean a clot. Get medical help right away for any of these.
Key takeaways
- Tirzepatide slows stomach emptying, which can change how warfarin tablets are absorbed.
- The Mounjaro and Zepbound labels name warfarin as a medicine to monitor.
- No warfarin study is on the labels; two case reports describe INR changes in opposite directions.
- The effect is largest after the first dose, so starting tirzepatide and each dose increase are the times to ask about extra INR checks.
- Never change your warfarin dose on your own; report bleeding or bruising.
